Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach
Alexander F C Hulsbergen1,2, Yu Tung Lo1,2, Ilia Awakimjan1
1Computational Neuroscience Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
A new model predicts 6-month survival for patients undergoing brain metastases (BM) resection, offering better risk stratification than existing methods. This tool aids in surgical decision-making for brain tumor patients.
Area of Science:
- Neurosurgery
- Oncology
- Machine Learning
- Biostatistics
Background:
- Current prognostic models for brain metastases (BM) are primarily based on radiotherapy patients, limiting their applicability to surgical cases.
- There is a need for reliable prognostic tools specifically for patients undergoing surgical resection of brain metastases.
Purpose of the Study:
- To develop and validate a machine learning model for predicting 6-month survival in patients after brain metastases resection.
- To compare the performance of various machine learning algorithms against established prognostic models.
Main Methods:
- Utilized a dataset of 1062 patients who underwent resection for brain metastases, split into training and testing sets.
- Trained and evaluated seven machine learning algorithms, including logistic regression, and compared them with the diagnosis-specific graded prognostic assessment.
- Assessed model performance using area under the curve (AUC) and calibration metrics.
Main Results:
- Logistic regression demonstrated the best performance with an AUC of 0.71 and strong calibration.
- The developed model effectively stratified patients into distinct risk groups (regular, high, very high) for 6-month mortality.
- The model's predictions significantly correlated with both 6-month and longitudinal overall survival (P < .0005).
Conclusions:
- A validated prediction model for 6-month survival post-neurosurgical resection of brain metastases has been developed.
- The model provides accurate risk stratification, aiding clinical decision-making for neurosurgical oncology patients.
- External validation is recommended for future research to confirm the model's generalizability.
More Related Videos
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
